On November 2, 2026 PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation (TWSE: 6446), a global biopharmaceutical innovator based in Taiwan leveraging deep expertise and proven scientific principles to deliver new biologics in hematology and oncology, reported that members of its management team will participate in the following investor conferences:
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Jefferies London Healthcare Conference
Date: November 16-19, 2026
Location: London, United Kingdom
Citi’s 2026 Global Healthcare Conference
Date: December 1-3, 2026
Location: Miami, Florida
Management will be available for investor meetings at both conferences. Investors interested in meeting with management should contact their Jefferies or Citi representative.
(Press release, PharmaEssentia, NOV 2, 2026, View Source [SID1234674058])